Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Alzheimer's disease and glaucoma - Reply
Alzheimer's Disease-Like Impaired Cognition in Endothelial-Specific Megalin-Null Mice
Alzheimer's disease research in the future: bibliometric analysis of cholinesterase inhibitors from 1993 to 2012
Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection
Alzheimer%26apos;s Disease In African Americans: Risk Factors And Challenges For The Future
Alzheimer%26apos;s Disease-Like Pathology Induced by Amyloid-beta Oligomers in Nonhuman Primates
Alzheimer's Disease and Amnestic Mild Cognitive Impairment Weaken Connections Within the Default-Mode Network: A Multi-Modal Imaging Study
Alzheimer's Disease: Evidence for the Expression of Interleukin-33 and Its Receptor ST2 in the Brain
Alzheimer%26apos;s disease and Parkinson%26apos;s disease genome-wide association study top hits and risk of Parkinson%26apos;s disease in Korean population
Alzheimer%26apos;s Disease Topics Related to Assessment and Intervention
Alzheimer%26apos;s Interventions: Pharmaceutical and Behavioral
Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on?
Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-beta brain balance and the putative role of PPARs
Alzheimer disease therapy-moving from amyloid-beta to tau
Alzheimer%26apos;s Disease
Alzheimer%26apos;s disease: analysis of a mathematical model incorporating the role of prions
Alzheimer Peptides Aggregate into Transient Nanoglobules That Nucleate Fibrils
Alzheimer's as a metabolic disease
Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting
Alzheimer's disease and CADASIL are heritable, adult-onset dementias that both involve damaged small blood vessels
Alzheimer's Associated beta-Amyloid Protein Inhibits Influenza A Virus and Modulates Viral Interactions with Phagocytes
Alzheimer's-related changes in non-demented essential tremor patients vs. controls: Links between tau and tremor?
Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936
Alzheimer%26apos;s Disease, Mild Cognitive Impairment, and Subjective Memory Loss
Alzheimer%26apos;s Disease and the Frontotemporal Dementias: Contributions to Clinico-Pathological Studies, Diagnosis, and Cognitive Neuroscience
Alzheimer%26apos;s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Alzheimer's Disease is Associated with Decreased Risk of Cancer-Specific Mortality: A Prospective Study (NEDICES)
Alzheimer%26apos;s A beta 10-40 Peptide Binds and Penetrates DMPC Bilayer: An Isobaric-Isothermal Replica Exchange Molecular Dynamics Study
Alzheimer%26apos;s Disease and the Quest for its Biological Measures
Alzheimer%26apos;s disease and the microbiome
Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function
Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations
Alzheimer%26apos;s Disease: Analyzing the Missing Heritability
Alzheimer's gamma-secretase under arrestin
Alzheimer Disease Risk Factors
Alzheimer's disease causation by copper toxicity and treatment with zinc
Alzheimer Disease Biomarker Testing in Cerebrospinal Fluid: A Method to Harmonize Assay Platforms in the Absence of an Absolute Reference Standard
Alzheimer and platelets: Low-density platelet populations reveal increased serotonin content in Alzheimer type dementia
Alzheimer's Disease Susceptibility Genes APOE and TOMM40, and Hippocampal Volumes in the Lothian Birth Cohort 1936
Alzheimers disease and granulocyte density diversity
Alzheimer's Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Alzheimer Risk Variant CLU and Brain Function During Aging
Alzheimer%26apos;s drugs linked to reduced risk of myocardial infarct
Alzheimer's Disease and Cancer: Current Epidemiological Evidence for a Mutual Protection
Alzheimer Disease and Diabetes Mellitus: Do They have Anything in Common?
Alzheimer's Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions
Alzheimer%26apos;s phenotypes induced by overexpression of human presenilin 2 mutant proteins stimulate significant changes in key factors of glucose metabolism
Alzheimer's Disease Genetics: From the Bench to the Clinic
Alzheimer's disease mutations in APP but not gamma-secretase modulators affect epsilon-cleavage-dependent AICD production
Alzheimer disease and risk of stroke A population-based cohort study
Alzheimer%26apos;s disease patients not carrying the apolipoprotein E epsilon 4 allele show more severe slowing of oscillatory brain activity
Alzheimer disease A tale of two prions
Alzheimer's and Parkinson's diseases: An environmental proteomic point of view
Alzheimer%26apos;s disease: amino acid levels and brain metabolic status
Alzheimer%26apos;s disease: connecting findings from graph theoretical studies of brain networks
Alzheimer%26apos;s disease: An update of the roles of receptors, astrocytes and primary cilia (Review)
Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood
Alzheimer's disease and other dementias: advances in 2013
Alzheimer's disease: which type of amyloid-preventing drug agents to employ?
Alzheimer%26apos;s and prion diseases: PDK1 at the crossroads
Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers
Alzheimer's Disease-A Panorama Glimpse
Alzheimer disease-like cellular phenotype of newborn granule neurons can be reversed in GSK-3 beta-overexpressing mice
Alzheimer%26apos;s Disease Dementia Guidelines for Diagnostic Testing: A Systematic Review
Alzheimer Disease Biomarker Detection Through Electrocatalytic Water Oxidation Induced by Iridium Oxide Nanoparticles
Alzheimer%26apos;s Disease: Identification and Development of -Secretase (BACE-1) Binding Fragments and Inhibitors by Dynamic Ligation Screening (DLS)
Alzheimer's disease: is a vaccine possible?
Alzheimer%26apos;s Disease and Antioxidant Therapy: How Long How Far?
Alzheimer%26apos;s disease treated patients showed different patterns for oxidative stress and inflammation markers
Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-beta Peptide Injection in Rats
Alzheimer%26apos;s Disease-Related Lesions
Alzheimer%26apos;s Silent Partner: Cerebral Amyloid Angiopathy
Alzheimer's disease and disseminated mycoses
Alzheimer Pathology and Angiotension Receptor Blockers Reply
Alzheimer's disease and olfaction
Alzheimer's disease: Review of hormone therapy trials and implications for treatment and prevention after menopause
Alzheimer's disease: functional decline and stage of dementia
Alzheimer%26apos;s Disease Costs: What We Know and What We Should Take into Account
Alzheimer%26apos;s disease and mortality in traditional long-term care facilities
Alzheimer病血脂代谢异常的研究
Alzheimer病的分子遗传学研究进展
Alzheimer病的神经心理学和有关检查的相关性研究(1)AD和正常老人检查结果比较: